298 related articles for article (PubMed ID: 21112201)
41. [Advanced glycation end products (AGEs), free radicals and diabetes].
Gillery P
J Soc Biol; 2001; 195(4):387-90. PubMed ID: 11938555
[TBL] [Abstract][Full Text] [Related]
42. Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts.
Ramasamy R; Yan SF; Schmidt AM
Mol Nutr Food Res; 2007 Sep; 51(9):1111-5. PubMed ID: 17854009
[TBL] [Abstract][Full Text] [Related]
43. Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis.
Röcken C; Kientsch-Engel R; Mansfeld S; Stix B; Stubenrauch K; Weigle B; Bühling F; Schwan M; Saeger W
Am J Pathol; 2003 Apr; 162(4):1213-20. PubMed ID: 12651613
[TBL] [Abstract][Full Text] [Related]
44. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
Lalla E; Lamster IB; Schmidt AM
Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
[TBL] [Abstract][Full Text] [Related]
45. [The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus].
Ksiazek K; Wiśniewska J
Przegl Lek; 2001; 58(10):915-8. PubMed ID: 11957818
[TBL] [Abstract][Full Text] [Related]
46. [Advanced glycation end products and hyperglycaemia].
Omsland TK; Bangstad HJ; Berg TJ; Kolset SO
Tidsskr Nor Laegeforen; 2006 Jan; 126(2):155-8. PubMed ID: 16415936
[TBL] [Abstract][Full Text] [Related]
47. Advanced glycation end products and their receptor contribute to ovarian ageing.
Stensen MH; Tanbo T; Storeng R; Fedorcsak P
Hum Reprod; 2014 Jan; 29(1):125-34. PubMed ID: 24256989
[TBL] [Abstract][Full Text] [Related]
48. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress.
Chekir C; Nakatsuka M; Noguchi S; Konishi H; Kamada Y; Sasaki A; Hao L; Hiramatsu Y
Placenta; 2006; 27(2-3):225-33. PubMed ID: 16338468
[TBL] [Abstract][Full Text] [Related]
49. GDPs and AGEs: impact on cardiovascular toxicity in dialysis patients.
Himmele R; Sawin DA; Diaz-Buxo JA
Adv Perit Dial; 2011; 27():22-6. PubMed ID: 22073823
[TBL] [Abstract][Full Text] [Related]
50. Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury.
de la Maza MP; Uribarri J; Olivares D; Hirsch S; Leiva L; Barrera G; Bunout D
Rejuvenation Res; 2008 Dec; 11(6):1041-8. PubMed ID: 19086911
[TBL] [Abstract][Full Text] [Related]
51. Role of advanced glycation end products in cellular signaling.
Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
[TBL] [Abstract][Full Text] [Related]
52. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
Lalla E; Lamster IB; Stern DM; Schmidt AM
Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
[TBL] [Abstract][Full Text] [Related]
53. Diabetic vascular disease: it's all the RAGE.
Hudson BI; Wendt T; Bucciarelli LG; Rong LL; Naka Y; Yan SF; Schmidt AM
Antioxid Redox Signal; 2005; 7(11-12):1588-600. PubMed ID: 16356122
[TBL] [Abstract][Full Text] [Related]
54. Advanced glycation endproducts and their pathogenic roles in neurological disorders.
Münch G; Westcott B; Menini T; Gugliucci A
Amino Acids; 2012 Apr; 42(4):1221-36. PubMed ID: 20949363
[TBL] [Abstract][Full Text] [Related]
55. Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels.
Downs CA; Kreiner LH; Johnson NM; Brown LA; Helms MN
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):75-87. PubMed ID: 24978055
[TBL] [Abstract][Full Text] [Related]
56. Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.
Nedić O; Rattan SI; Grune T; Trougakos IP
Free Radic Res; 2013 Aug; 47 Suppl 1():28-38. PubMed ID: 23692178
[TBL] [Abstract][Full Text] [Related]
57. [Effects of advanced glycation end products and its receptor on oxidative stress in diabetic wounds].
Niu YW; Miao MY; Dong W; Dong JY; Cao XZ; Lu SL
Zhonghua Shao Shang Za Zhi; 2012 Feb; 28(1):32-5. PubMed ID: 22490537
[TBL] [Abstract][Full Text] [Related]
58. Hyperglycemia and glycation in diabetic complications.
Negre-Salvayre A; Salvayre R; Augé N; Pamplona R; Portero-Otín M
Antioxid Redox Signal; 2009 Dec; 11(12):3071-109. PubMed ID: 19489690
[TBL] [Abstract][Full Text] [Related]
59. Receptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease?
Chen L; Liu L; Wang T; Shen YC; Wen FQ
Arch Med Res; 2013 Jan; 44(1):75-6. PubMed ID: 23287523
[TBL] [Abstract][Full Text] [Related]
60. AGE-RAGE in multiple sclerosis brain.
Sternberg Z; Ostrow P; Vaughan M; Chichelli T; Munschauer F
Immunol Invest; 2011; 40(2):197-205. PubMed ID: 21080832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
